Financials
- Market Capitalization 3.47 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
51.34
Rapporto prezzo/fatturato
6.56
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1511 | TNGX Tango Therapeutics, Inc. - Common Stock | 22.22 USD | -8.07% | +2.68% | -9.49% | +154.23% | 3.75 B USD | ||
| 1518 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.92 USD | -3.28% | -0.82% | -13.47% | +73.06% | 3.70 B USD | ||
| 1581 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 34.42 USD | -3.88% | -4.89% | -40.79% | -15.62% | 3.33 B USD | ||
| 1588 | LEGN Legend Biotech Corporation - American Depositary Shares | 17.88 USD | +0.45% | -4.79% | -3.87% | -44.09% | 3.31 B USD |